Oppenheimer Upgrades Dyne Therapeutics (DYN) to Outperform
Tweet
Share
E-mail
Get Alerts DYN Hot Sheet
Price: $23.74 --0%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 41
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 41
Join SI Premium – FREE
Oppenheimer analyst Jay Olson upgraded Dyne Therapeutics (NASDAQ: DYN) from Perform to Outperform with a price target of $40.00 (from $11.00).
For an analyst ratings summary and ratings history on Dyne Therapeutics click here. For more ratings news on Dyne Therapeutics click here.
Shares of Dyne Therapeutics closed at $18.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Houthis Announces 'sea Navigation Ban' On Saudi Arabia - Bloomberg
- KeyBanc on Micron Technology (MU)
- Alexandria delivers 427,000 RSF R&D hub for Bristol Myers Squibb in San Diego
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
